Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Xellia Pharmaceuticals ApS

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 2,539,716 More Arrow 2,996,552 More Arrow 3,178,322
Earnings before taxes 1,545,971 Less Arrow -3,209,582 More Arrow -360,400
Total assets 5,082,137 Less Arrow 3,174,802 More Arrow 4,898,127
Current assets 2,217,120 Less Arrow 1,994,886 Less Arrow 1,515,900
Current liabilities 3,810,299 Less Arrow 3,081,694 Less Arrow 1,550,626
Equity capital 257,966 Less Arrow -901,575 More Arrow 2,478,155
- share capital 319,175 Less Arrow 303,152 Less Arrow 284,524
Employees (average) 750 Less Arrow 350 Equal arrow 350

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 5.1% Less Arrow -28.4% More Arrow 50.6%
Turnover per employee 3,386 More Arrow 8,562 More Arrow 9,081
Profit as a percentage of turnover 60.9% Less Arrow -107.1% More Arrow -11.3%
Return on assets (ROA)
Current ratio 58.2% More Arrow 64.7% More Arrow 97.8%
Return on equity (ROE) 599.3% Less Arrow 356.0% Less Arrow -14.5%
Change turnover -615,220 More Arrow -389,855 More Arrow 640,784
Change turnover % -20% More Arrow -12% More Arrow 25%
Chg. No. of employees 400 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 114% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.